1. Cumulated survival rate for follow-up 24 weeks was significantly improved (MSC group vs. control, 73.2% v.s. 55.6%)2. The laboratory indexes, including alanine aminotransferase (ALT) and albumin (ALB) had significantly improved in MSC group at week 1, and MELD score dramatically decreased at week1 and 23. The incidence of severe infection in the MSC group was much lower. This evidence concerns the gene GPT and infection.